CTSA Biostatisticians Work Log | Consult Time Log | Coordinating VU and Meharry Activities


Recurring

  • Clinics
  • Friday morning CRC Skills Workshop (Li, often: Dan and Chang; some of us give lectures)
  • VICTR Operations Workgroup meetings (Frank and Dan)
  • VICTR SRC (All)
  • Monthly Biostatistics & Biomedical Research Ethics meeting starting 12/07
  • Biweekly Biostatistics meeting starting 23Jan08

Dan Byrne

  • 1/4/08 - Assisted CRC investigator with analysis for abstract - Dr. Julia Dunn.
  • 1/4/08 - CRC Research Skills Workshop.
  • 1/4/08 - Worked on the Studio planning.
  • 1/9/08 - Participated in the Studio for Dr. Ramos.
  • 1/9/08 - Participated in the SRC.
  • 2/21/08 - Participated in cardiovascular clinical trial pre-planning meeting (David Maron, PI)
  • 3/4/08 - Participated in the Studio for Dr. ShelagThe Analysis of Biological Data, Second Editionh A.Mulvaney.
  • 3/4/08 - Met with Dr.Kelly Birdwell for protocol 1570.
  • 08/20/08 - 09/09/08 Met with Kelly Birdwell and Li Wang and worked on her manuscript revision
  • 08/21/08 - Reviewed protocols PF219 and PN_1900
  • 09/12/08 - Reviewed protocols PF238 and PF236
  • 09/23/08 - Reviewed protocol 231
  • 10/10/08 - Reviewed protocol PF245
  • 10/22/08 - Reviewed protocols PF260 and PF267
  • 10/24/08 - Met with Dr.Natalie Curcio and Li Wang on USNO project
  • 10/31/08 - Met with Kelly King and Li Wang on her study design
  • 11/14/08 - Reviewed protocols PF271, PF279, PF280, and PF285
  • 11/27/08 - Reviewed protocols PF293, PF294, PF297, PF310, PF311, and PF312
  • 12/19/08 - Reviewed protocol PF317
  • 12/21/08 - Reviewed protocol PF331
  • 01/19/09 - Reviewed protocol PF356
  • 01/23/09 - Reviewed protocol PF360
  • 03/02/09 - Reviewed protocols PF345 and PF380

Rafe Donahue

  • 01/09/08 - Participated in the Studio for Dr. Ramos
  • 01/09/08 - Participated in the SRC.
  • 01/15/08 - Protocol reviews.
  • 01/15/08 - Ethics meeting.
  • 01/18/08 - Investigator consult.
  • 01/21/08 - Studio planning.
  • 01/22/08 - Participated in the Studio for Dr. Guzman
  • 01/23/08 - Participated in the SRC
  • 01/23/08 - Biweekly biostat CTSA mtg.
  • 01/24/08 - Protocol reviews.
  • 01/30/08 - Protocol reviews.
  • 02/01/08 - Protocol reviews.
  • 02/05/08 - Studio planning.
  • 02/06/08 - Studio participation.
  • 02/08/08 - Protocol reviews.To identify and functionally characterize novel genetic variants in NUP155, hCG1 and GLE1 associated with atrial fibrillation
  • 02/12/08 - Investigator consult.
  • 02/13/08 - Biweekly biostat CTSA mtg.
  • 02/14/08 - Protocol reviews.
  • 02/19/08 - CTSA ethics mtg.
  • 02/20/08 - SRC mtg.
  • 02/21/08 - Protocol reviews.
  • 02/25/08 - Protocol reviews.
  • 02/26/08 - Protocol reviews.
  • 02/27/08 - Biweekly CTSA mtg.
  • 03/03/08 - Studio planning.
  • 03/04/08 - Participated in the Studio for Dr. Shelagh A.Mulvaney.

Frank Harrell

2007

  • 12 - Organized meetings of biostatisticians and research ethicists, take minutes of meetings on twiki
  • 12/18 - Reviewed 1778

2008

  • 1 - Made studio assignments, add to web site
  • 1/14 - 1/18 - presented 15-hour short course Regression Modeling Strategies, open to all VU researchers with some regression experience
  • 1/15 - Ran monthly meeting with ethicists, took minutes
  • 1/18 - Met with Paul Harris to coordinate RedCap/R linkage; Biostatistics will assist with a binary R export
  • 1/22 - Update web site
  • Winter 2008 Semester: Co-taught IGP 304: Introduction to Statistics for Biomedical Researchers
  • Fall 2007 - Spring 2008: Co-taught Introduction to Biostatistics for Clinical Investigators to Clinical Pharmacology Fellows
  • 1/29 - Participated in CTSA BERD Evaluation Task Force conference call
  • 1/30-2/1 - Attended 3-day program in Bayesian biostatistics and adaptive design at MD Anderson Cancer Center
  • 2/7 - 30-minute phone call to advise Hye-Seung Lee of U. South Florida regarding stat plan for a protocol submitted to CTSA
  • 2/6 - Chaired design studio for Don Arnold's funded asthma grant
  • 2/8 - Provided info about VU proposal to NIH CTSA wiki
  • 2/12 - Participated in CTSA BERD consortium electronic information committee one-hour teleconference
  • 2/21 - Participated in cardiovascular clinical trial pre-planning meeting (David Maron, PI)
  • 2/27 - Expert statistician for T2 Hypothesis Study for Dr Uchechukwu Sampson's project Davidson County Health Disparies Project: Planning Implementing, and Monitoring Change in Cardiovascular Outcomes
  • 2/29 - Conducted online web broadcast to demonstrate our department's wiki system to the national CTSA BERD Online Resources and Education Task Force
  • 3/7 - 2nd meeting David Maron
  • 3/11 - 3rd meeting David Maron
  • 3/17 - Reviewed protocol 1815
  • 3/21 - 4th meeting David Maron
  • 3/24 - Partipated in special Biostat/Ethics clinic for assisting with study execution in Sports Medicine
  • 4/3 - Participated in Design Studio for Bradley VanSickle MD PhD on hyperglycemia-induced inflammation in cystic fibrosis
  • 4/15 - Reviewed pilot study proposals 1830 (primary) and 1808 (secondary)
  • 5/6 - Reviewed Haydar Frangoul's COBLT analysis study (originally GCRC-funded)
  • 5/7 - Reviewed Tina Hartert pilot study application
  • 5/8 - Met with Jirong Long (with Lei Xu) to go over statistical critique of protocol # 1830 and areas for future methodologic development; critique might also benefit an upcoming grant proposal
  • 5/10 - Assisted Dan Byrne in reviewing protocol 1847 (Pooled Analysis of Tea Comsumption and Endometrial Cancer Risk)
  • 5/10 - Reviewed Jirong Long's resubmission of # 1830
  • 5/12 - Participated in analysis & design studio for Sunil Kripalani on NIH funded study about to begin
  • 5/14 - Planning meeting with Gordon Bernard, Dan Byrne
  • 5/16 - Design and analysis studio for Alecia Fair - breast density, race & vitamin D (T2)
  • 5/18 - Reviewed clarifications of Tina Hartert's proposal 1846
  • 5/19 - Conducted Biostat Clinic to assist Sandy Deming with protocol 1847 stat critique
  • 5/29 - Met with Dr Frangoul and Li Wang to plan analyses for project previously approved for funding in the GCRC model
  • 6/2 - Reviewed proposal by Dr Maron to outside executive committee
  • 6/3 - Reviewed protocol 1867 (Heckers)
  • 6/3 - Reviewed protocol 1862 (VanDervoort)
  • 6/3 - Reviewed protocol 1873 (Wendy Stone, repository study)
  • 6/11 - Reviewed biostatistical plan for Lara Hershcovitch proposal on neural dissociation in Parkinson's disease
  • 6/13 - Reviewed protocol 1878 (Allen; chemokines in h. pylori-induced eosinophil migration)
  • 7/10 - Handling questions about multiple past reviews
  • 7/25 - Moderated Marshall Summer manuscript studio on Ethnic-Specific Polymorphisms in Catalytic Subunit of GCL
  • 7/25 - Met with Li Wang to assist with Franqoul analysis (also 8/18, 8/20)
  • 8/15 - Assigned 5 studios for biostat experts
  • 8/30 - Assigned studios
  • 9/3 - Met with David Maron to critique web survey
  • 9/4 - Assigned several studios
  • 9/9 - Pre-reviewed proposal for Ken Monahan (also did two biostat clinics for him)
  • 9/10-10/1 - Numerous biostat voucher request reviews and studio assignments
  • 10/2 - Participated in and moderated studio for Jin Han on delirium in the ED
  • 11/5 - Meet with H Frangoul about analyses for meeting presentation
  • 11/21 - Attended and presented at the BERD national meeting, Rockville MD
  • 12/10 - Studio for Storrow and Naftilan on heart failure literacy
  • 12/11 - Studio for Heidi Silver on dietary fat and heart failure progression
  • 12/15 - Moderated studio for Dennis Hallahan on targeted drug delivery to cancer
  • 12/23 - Edited Frangoul manuscript

2009

  • 1/3 - reviewed PF346 Shibao - autonomous nervous system, NO, hypertension and insulin resistance in African American women
  • 1/4-2/20 - Assigned several studios
  • 2/20 - Studio for Liana Castel: Arthralgia syndrome in women with breast cancer treated with aromatase inhibitors
  • 2/25 - Conference call for new BERD online journal subcommittee
  • 3/2 - Reviewed protocol PF378 on Crohn's disease
  • 3/6 - Voucher (with T Scott) initial meeting with Jonathan Soslow and David Parra; early diagnosis of coarctation of the aorta in neonates; one hour meeting
  • 3/13 - Reviewed protocol PF415 on Crohn's disease
  • 4/2 - Meeting with David Maron to go over survey analysis from Terri Scott
  • 4/2 - Study Design Studio for Susan Bell (Cardiovascular Medicine): Late Na Channel Blockade in Diastolic Dysfunction
  • 4/9 - Voucher to assist in study design for Gordon Bernard's clinical trial on effect of albumin loading vs. saline on CVP - plasma colloid oncotic pressure gradient
  • 4/20 - Studio for Gordon Bernard: Facilitated model to eliminate duplication in IRB review of multi-center trials
  • 4/20 - Voucher for statistical analysis for Doug Atkinson for comparing gold standard O2 sats with two monitoring devices in pediatric cardiology (Nate Mercaldo is main statistician); 0.5h
  • 5/1-present - extensive work on design of WISDOM clinical trial for David Maron
  • 5/13 - Hypothesis Generating Studio for Ken Monahan on Intra-cardiac BNP levels
  • 6/17 - Reviewed protocol VR115 (Abunrad fatty liver disease)
  • 5/1 - 7/28 - Worked with Nate Mercaldo on voucher for SPO2 instrumentation accuracy study for Dr Atkinson
  • 8/10 - 2nd Meeting with Kevin Niswender - insulin and weight loss study
  • 8/20 - Study Design Studio for Meg Benningfield - Disruption of early attachment in Opioid Dependence: Pharmacogenetic study of methadone vs. Buprenorphine treatment during pregnancy
  • 8/23 - Pre-review VR207 - postop care for laryngectomy
  • 8/23 - Pre-review VR244 - Finding new candidate drugs for Pulmonary Arterial Hypertension
  • 9/16 - Pre-review VR376 - Obesity hypertension in African American women: Neuro-metabolic mechanisms
  • 9/16 - Pre-review VR340 - Florez: Observational study to determine the correlation between plasma concentrations of the urea cycle intermediates, nitric oxide metabolites and isoprostane levels with the severity and progression of respiratory distress in the newborn period (voucher request for data analysis assistance to finish requirements for fellowship)
  • 9/17 - Pre-review VR249 - Alison Miller - Safety and efficacy of VX-770 in subjects aged 12 years and older with Cystic Fibrosis who are homozygous for the F508del-CFTR gene mutation
  • 9/27 - Pre-review VR176 - Statins in burn patients
  • 10/02 - Re-review VR376
  • 10/26 - Pre-review VR364 - Cristman - Activation of TRPV-4 and PADI-2/4 in the Asthmatic Airway after Antigen Challenge
  • 11/16 - Meet with Haydar Frangoul and Li Wang for one hour to discuss new questions related to cells destroyed from the freezing/thawing process
  • 11/17 - Pre-review VR515 - Shibao - Obesity, Hypertension in African American Women: Autonomic & Nitric Oxide Contribution
  • 11/17 - Pre-review VR507 - Haas - Pharmacogenetics of Efavirenz among HIV-infected South Africans
  • 11/17 - Pre-review VR540 - Simmons - Blood draw add-on to funded grant
  • 11/17 - Pre-review VR476 - Mixon - Detection of Donor-derived DNA in semen samples among recipients of allogeneic hematopoietic stem-cell transplants
  • 11/30 - Moderated and served as expert for Study Design Studio for William Bradham for K23 application: Myocardial hemorrhage, oxidative stress and remodeling in MI
  • 12/18 - MSCI Study Design Studio for Andrea Ramirez, Clin Pharm Fellow

2010

  • 1/6 - Pre-review VR576: The functional expression of IL-13 receptor on human CD4+ T lymphocytes (Peebles)
  • 1/23 - Pre-review VR476 (2nd submission)
  • 2/9 - Moderate and participated in design studio for Patrick Henson: Pain-related alterations in somatologic maps following total knee arthroplasty
  • 2/12 - Pre-review VR564: Utility of actigraphy, electrodermal activity, and polysomnography (Malow)
  • 2/18 - Meet with Haydar Frangoul and Li Wang about BMI paper
  • 3/29 - Re-review VR364 (2nd round)
  • 3/31 - Re-review VR576 (2nd round, Peebles)
  • 4/14 - Pre-review CRC1537.1 (1st round, Walker): Chronic Abdominal Pain
  • 4/14 - Pre-review VR464 (1st round, Tiffany Walker): HIV, Adhesion Molecules, and Apoptosis
  • 4/14 - Pre-review VR576 (3rd round; Stokes Peebles): Functional expression of IL-13 receptor on human CD4+ T lymphocytes
  • 4/28 - Pre-review VR907 (Haas, Birdwell; Pharmacogenomics of Solid Organ Transplantion)
  • 5/11 - Design Studio for Charlene Dewey: Simulation to improve controlled substance prescriptions
  • 5/13 - Pre-review VR464 (2nd round, Tiffany Walker); problems noted in original review nicely dealt with in clinic
  • 5/13 - Pre-review VR837 (1st round, Grayson, Gene Expression of Metabolic Disorders)
  • 5/20 - Design Studio for Rebecca Scalzo and Zack Klint: Post-CABG Cardiac Rehab trial
  • 5/25 - Re-review VR576 (3rd round, Peebles)
  • 6/19 - Pre-review VR 465 (Tiffany Taylor; flow cytometry, apoptosis)
  • 8/24 - Pre-review VR1140 (Clinton Devin;Thrombin Generation Assay in Total Joint Arthroplasty)
  • 9/28 - Pre-review VR1137 (Sarika Peters; Rett Syndrome Disorders and Angleman Syndrome as Genetic Models of Autism Spectrum Disorder)
  • 10/17 - Pre-review VR407 (Debra Friedman and John Greer; Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma; stat plan by E Koehler)
  • 10/18 - Pre-review VT1240 (Pulley, Clayton: Translating Pharmacogenomic Research to the Clinic: PREDICT Focus Groups Phase 2)
  • 11/15 - Pre-review CRC1676.1 (Kanika Bagai: Variability of Fibrinolytic Markers and Endothelial Function in Obstructive Sleep Apnea)
  • 12/15 - Moderated studio for Hak-Joon Sung (Biomed End): Decoupling mechanical cues between inflammation and hypertension
  • 12/22 - Special clinic for George and Heitkamp on NEC and bacterial genetics

2011

  • 1/3 - Pre-review CRC1497.R1 (Burk: Selenium Supplementation of Patients with Cirrhosis)
  • 1/28 - Pre-review VR1536 (Lilian Nanney:A Pilot/Feasibility Study on Wound Repair and Body Contouring after Gastric-Bypass)
  • 1/9 - Pre-review round 2 VR1536
  • 1/9 - Pre-review round 3 VR71 (Towse:Mitochondrial Function in Skeletal Muscle of Patients with Amyotrophic Lateral Sclerosis)
  • 2/17 - Teleconference regarding sexual assault survey proposal (with Sheila Ridner, Mary Dietrich, Carrie Carretta)
  • 2/22 - Pre-review round 1 VR212 (Alfredo Gamboa:Autonomic evaluation in obesity associated hypertension)
  • 2/23 - Pre-review VR1397 (Abumrad:Effects of Caloric Restriction Alone vs Postoperative Caloric Restriction Following Bariatric Surgery on Glucose Metabolism in Patients with Diabetes Mellitus)
  • 3/15 - Pre-review VR1460 (N Brown:RENIN-ANGIOTENSIN AND FIBRINOLYSIS INTERACTION IN HUMANS; Effect of Long-Term PDE5 Inhibition on Glucos Homeostasis)
  • 3/31 - Pre-review VR1531 (Haman:Origins of Cognitive Dysfunction in Postural Tachycardia Syndrdome (POTS): A Pilot Study)
  • 4/10 - Second round VR1531
  • 4/11 - Pre-review VR1713 (Boutaud: Isolation of APP-Beta specific monoclonal antibodies)
  • 4/22 - Studio: Ehab Kasasbeh: Intracoronary Adriamycin for the Treatment of Cardiac Septal Hypertrophy
  • 4/26 - Pre-review VR1632 (Jun Li: The Biological Function of SVIP)
  • 4/29 - Studio: Sunil Kripalani - Systemic review of readmission risk models
  • 5/6 - Pre-review VR1797 (Kathryn Miller: The burden of human rhinovirus infection in adults with acute respiratory illness visits)
  • 5/14 - Pre-review VR1794 (Phillip Lammers: Impact of BRAF mutational status of colorectal cancer in African-American patients)
  • 5/14 - Pre-review VR1752 (Gregory Barnes:The Vanderbilt Natural History Study of Epilepsy in Autism Spectrum Disorders)
  • 5/14 - Pre-review VR1797, Round 2 (Kathryn Miller: The burden of human rhinovirus infection in adults with acute respiratory illness visits)
  • 7/8 - Pre-review VR1794 round 3
  • 7/21 - Pre-review VR1813 (Salyka Sengsayadeth: Impact of CTLA4 Single Nucleotide Polymorphisms (SNPs) on Outcome after Unrelated Donor Hematopoeitic Stem Cell Transplant)
  • 7/29 - Studio: Quinn Wells: Chemotherapy-based heart failure toxicity and polymorphisms
  • 8/3 - Pre-review VR412 (James Crowe:(CRO19) TISSUE: Immune Cells and Soluble Factors from Healthy Donors)
  • 8/4 - Studio: Joseph Fanning: SEE Project: Setting Expectations Early in the ICU
  • 8/16 - Pre-review VR1813 (round 2)
  • 8/29 - Studio: Sean Collins: Design of an adaptive trial for acute heart failure in the emergency department
  • 9/2 - Manuscript studio: Christianne Roumie: Comparative effectiveness of sulfonylurea and metformin monotherapy on risk of cardiovascular events in type 2 diabetes mellitus
  • 9/30 - Studio: Beth Malow: Sleep and Autism Intervention Network - Melatonin Trial
  • 10/7 - Studio: Mary Zutter: Managing the diagnostic challenges of hematolymphoid malignancies in the era of personalized and genomic medicine
  • 10/13 - Studio: Beth Malow: continuation of 9/30
  • 10/18 - Studio: Salyka Sengsayadeth: Impact of CTLA4 SNPs on outcome after unrelated donor dematopoietic stem cell transplant (moderated and participated)
  • 11/13 - Pre-review VR1660 (Monohan: Genetic contribution to atrial fibrillation in obstructive sleep apnea)
  • 11/19 - Pre-expert consult stat review: VR959 (William Westen: Clinical Trial Evaluating Telmisartan for the Treatment of Macroproteinuria Among HIV-1 Infected African American Adults Treated with Combination Antiretroviral Therapy)
  • 11/19 - Pre-review VR1660 (Monohan: Genetic contribution to atrial fibrillation in obstructive sleep apnea; round 1 again)
  • 12/3 - Studio: Sean Collins: Design of an adaptive trial for acute heart failure in the emergency department (2nd studio)
  • 12/23 - Pre-review VR2260 (Ivanov: Characterization of Neurotrophic Pathways Associated with Invasion)
  • 12/23 - Pre-review VR2613 (Haas: A Randomized Controlled Trial to Examine and Compare the Effects of HAART Versus Statin Therapy on Endothelial Function and Markers of Inflammation/Coagulation in Antiretroviral-Naive HIV-Infected Individuals with High CD4+ Cell Counts)

2012

  • 1/8 - Pre-review round 2 VR2613 (Haas; had failed round 1; protocol committee response to stat critique was inadequate so failed round 2)
  • 1/29 - Pre-review VR2612 (Snyder: Wound Classification in Pediatric General Surgery | clinic; passed)
  • 1/29 - Pre-review VR2260 (Ivanov: Characterization of Neurotrophic Pathways Associated with Invasion - see 12/23/11; failed round 2 - no investigator response to biostat critique, no FNR, no justification for power based on 1SD change, no specification of SD)
  • 2/4 - Pre-review round 1 VR3013 (Lisa Williams: fMRI Habituation in Patients with Schizophrenia; pass but replace analysis of % change with log ratio)
  • 2/4 - Pre-review round 2 VR2260 (Ivanov: Characterization of Neurotrophic Pathways Associated with Invasion - see 1/29; response was that FNR methods not available for rnaseq; no other response; inadequate; fail; Fei Ye stats)
  • 2/15 - VR1813 (Salyka Sengsayadeth: Impact of CTLA4 Single Nucleotide Polymorphisms (SNPs) on Outcome after Unrelated Donor Hematopoeitic Stem Cell Transplant)
  • 2/16 - VR2841 (Kimberly Bess; reviewed response to previous review re:nonresponse bias in survey; passed)
  • 2/23 - VR3094 (Advanced magnetic resonance imaging (MRI) methods as surrogate biomarkers for early treatment response in patients treated for glioma; pre-pre review failed;need to assess tumor at each time point and not change)
  • 2/24 - VR1813 (Salyka Sengsayadeth: Impact of CTLA4 Single Nucleotide Polymorphisms (SNPs) on Outcome after Unrelated Donor Hematopoeitic Stem Cell Transplant;pass)
  • 2/24 - Studio: Mary Zutter
  • 2/27 - VR2841 (Kimberly Bess: Nashville Promise Neighborhood Community Survey; pass pre-review)
  • 3/5 - VR2760 (Margaret Benningfield: Neurobiology of Impulsivity Risk and Reward in Youth at Risk for Addiction; pre-review R1; pass; need to not use stand. effect sizes)
  • 3/12 - VR3441 (Carrie Geissberg:Heart Transplant Survival Outcomes in Adriamycin Dilated Cardiomyopathy; review pilot study proposal to see if needs developmental support;biostatistics assigned: Harrell, Wang)
  • 3/20 - Studio: Sarah Nechuta: Vitamin supplement use, oxidative stress, and breast cancer prognosis
  • 4/10 - Design Studio: Lynette Henderson: Autism telephone support program evaluation
  • 4/12 - Design Studio: Paul Harris: Researchmatch.org 2.0
  • 4/10 - Analysis/Implementation Studio: Pingsheng Wu: Immunoprophylaxis of respiratory syncytial virus and respiratory syncytial virus induced morbidity in high-risk infants (also moderated)
  • 6/19 - Pre-review VR3213 (Rothman: Rigorous Dietary Assessment in Two Year Old Children Participating in an RCT Obesity Prevention Trial)
  • 7/17 - Pre-review stat plan to see if OK for submission for pilot study: VR2911 (O'Brien)
  • 8/20 - VR2911 Pre-review (Christine O'Brien: Preterm Labor Raman Spectroscopy Study)
  • 8/27 - Grant Review Studio: Julia Noland: Neurodevelopmental functioning in children after early complex cardiac surgery
  • 8/31 - Pre-review VR4541 (Donna Seger: Intralipid emulsion pharmacokinetics)
  • 9/3 - Pre-review VR4752 (Tricia Thornton-Wells: Neuroimaging of Alzheimer's Disease in African Americans)
  • 9/7 - Design Studio: David Janz: Acetominophen for the reduction of oxidative stress in severe sepsis
  • 9/10 - Pre-review VR2911 round 2 (Christine O'Brien: Preterm labor raman spectroscopy study)
  • 10/21 - Pre-review VR5310 (John Koethe: Pilot Study of Extended-release Exenatide to Improve Glucose Control and Reduce Systemic Inflammation in Diabetic, HIV-infected Adults on Antiretroviral Therapy)
  • 10/31 - Pre-review VR5494 (Lawrence Gaines: Depression as a risk factor for exacerbation of Crohn's disease: a retrospective cohort study)
  • 11/1 - Moderate studio: Roshi Markley: Outcomes with intervention for aortic stenosis
  • 11/7 - Pre-review VR5597 (Tonia Rex, Ana De Lucas: Comparison of angiogenic activity of a EPO-R76E as compared to wild-type EPO); round 1
  • 11/12 - Meeting with investigators on liver glucose diabetes study proposal
  • 11/16 - Hypothesis Generation Studio: Carrie Geisberg Lenneman: Predicting adverse cardiac events in cancer treatment (PACE in Cancer Treatment R01)
  • 11/20 - Pre-review VR639.1 round 2 (Pratik Talati: Cerebral Blood Volume Mapping of the CA1 Subfield of the Hippocampal Formation in Schizophrenia) (Dan Byrne on vacation)
  • 12/09 - Pre-review VR6052 round 1 (David Janz: Acetaminophen for the Reduction of Oxidative Stress in Severe Sepsis)
  • 12/18 - Pre-review VR6111 (Daniel Lenihan: Improving Heart Failure Care Using Automatic Electronic Identifiers and a Transitional Care Team)
  • 12/18 - Pre-review VR6136 (Kevin Sexton: Real-Time Creatinine Clearance Monitoring to Detect Acute Kidney Injury in Trauma Patients)
  • 12/21 - Pre-review VR6161 (Dan France: Real-Time Forecasting of ICU Length of Stay)
  • 12/27 - Pre-pre review VR1010.R1 (Correa: Role of Helicobacter Ancestry in Gastric Carcinogenesis; biostatistician listed is Robertino Mera)

2013

  • 1/4 - Pre-review VR6136 (round 2)
  • 1/8:
  • VR6084: Darbar: Individualization of Prophylactic Therapy With the Use of a Clinical and Genetic Risk Score Will Prevent Postoperative Atrial Fibrillation and Improve Clinical Outcomes (rounds 1 and 2)
  • VR6157: Watkins: Improving NICU to OR Information Transfer through Patient Centered Handover Design
  • VR2847: Eagle: Development of mobile device application to expedite intervention for patients with acute coronary syndrome
  • VR6110: S Bell: Recognition and Imact of Frailty in Acute Care Cardiovascular Patients
  • VR6162: D Friedman: Personalized Risk Stratification for Lung Cancer Prevention, Early Detection and Smoking Cessation
  • VR1010.R1: Correa: Role of Helicobacter pylori (H. pylori) Ancestry in Gastric Carcinogenesis
  • VR6116: K Mukherjee: Increasing Insulin Resistance in Predicting Infection in Diabetic, Occult Diabetic, and Non-Diabetic Trauma Patients
  • VR6199: H Smith: Pediatric Delirium in Infants and Young Children: Validation of the PreSchool Confusion Assessment Method for the Intensive Care Unit (psCAM-ICU)
  • VR6136: Sexton: Real-Time Creatinine Clearance Monitoring to Detect Acute Kidney Injury in Trauma Patients (round 3; had suggested corr. precision)
  • VR5924: S Van Driest: Acute Kidney Injury Risk Notification in Pediatric Inpatients: A Pilot Adverse Drug Event Initiative
  • VR6125: D Byrne: Cornelius - A Randomized Controlled Trial of a Real-Time Personalized Predictive Modeling Decision Support System to Reduce Pressure Ulcers among Hospitalized Patients
  • VR6104: L Nanney: Early Detection of Patients at Risk for Development of Hospital Acquired Pressure Ulcers
  • VR6076: A Woodworth De Salvo: Identification and Validation of a Sepsis Risk Score to Predict Sepsis, its Severity and Outcome Among ED Patients with SIRS
  • 2/1: Research Design Studio: A Storrow: Chest Pain evaluation - ED vs outpatient testing
  • 2/1: Pre-review round 2 VR5979: B Creech: Prospective Analysis of a Novel Rapid Diagnostic Tool for Acute Osteoarticular Infections in Children
  • 2/1:Pre-review round 1 VR6210: G Fleming: A Retrospective Chart Review of Sodium Disturbances in Neonatal Patients Receiving Slow Continuous Ultra Filtration (SCUF) During Extracorporeal Membrane Oxygenation (ECMO)
  • 2/1: Grant review studio: J Wanderer: Improving Peri-Operative Blood Product Utilization through Intra-Operative Clinical Decision Support
  • 2/22: Design studio: S Van Driest: Acute Kidney Risk Notification in Pediatric Inpatients: A Pilot Adverse Drug Event Initiative
  • 3/1: Design studio: S Bell: Recognition and impact of frailty in acute care cardiovascular patients
  • 3/12: Pre-review VR5349.1 round 1: J Castilho: Hormonal Contraception and Risk of Non-AIDS-Defining Events (biostat request augmentation from $2000 to 130 hours)
  • 3/20: Grant Proposal studio: C McNaughton: ED: Role in hypertension care coordination and management (K23)
  • 3/20: Pre-review VR6852: J Rothschild: Permanent lead placement for sacral neuromodulation without fluoroscopy using anatomic landmarks and stimulated response: surgical technique and comparison of efficacy
  • 3/26: Grant Proposal studio: Ashley Shoemaker: Pseudohypoparathyroidism, energy imbalance, cognitive impairment, nutrient preference and hyperphagia
  • 3/27: Pre-review round 1: VR6659: CLR 01-2013: M Morral Nickelson: Host and Pathogen Risk Factors for Recurrent Clostridium difficile Infection (CDI) in Children
  • 4/2: Manuscript studio: Alan Storrow: NED
  • 4/15: Grant Proposal studio: J Ehrenfeld: Prospective evaluation of th eimpact of intraoperative glucose monitoring
  • 5/1: Grant Proposal Studio: Don Arnold: Asthma prediction rule impact: Improving acute asthma exacerbation outcomes
  • 5/7: Pre-review round 1: VR2610.1: T Thornton-Wells: MRI Biomarkers and Genetic Risk Factors for Alzheimer Disease
  • 5/21: Pre-review round 2: VR6659: M Nicholson: CLR 01-2013 Host and Pathogen Risk Factors for Recurrent Clostridium difficile Infection (CDI) in Children. https://starbrite.vanderbilt.edu/funding/src/index.html?action=view&tab=tabprerev&id=VR6659 info
  • 5/29: Pre-review round 1: VR7536: J Newman: Clinical Sites for an Undiagnosed Diseases Network U01. https://starbrite.vanderbilt.edu/funding/src/index.html?action=view&tab=tabprerev&id=VR7536 info
  • 5/30: Pre-review round 3: VR6659
  • 6/12: Studio: M Patel: TBI neurological function/treatment/ventilator-free days
  • 6/23: Pre-review round 1: VR: D Hood (MMC->OSU): Developing a Translational Methodology for Quantitative Assessment for Neurodevelopmental Deficits In a Minority Pediatric Infant Population (had one-hour meeting with PI 2 weeks prior to discuss statistical analysis; V Agboto unable to attend)
  • 6/256: Pre-review round 1: VR6236: B Eilertson: Improving Detection of Insertions, Deletions and Duplications in M. tuberculosis (fail - using FET, sens, spec, not clear if variables truly dichotomous)
  • 7/9: Pre-review round 2: VR6236 (changed FET to Pearson; still unclear about whether fundamental information is binary so that sens and spec are correct to use)
  • 7/11: Pre-review round 1 VR7611: Garland: Autonomic Assessment of a 15 year old Girl with a Congenital Absence of Norepinephrine
  • 7/12: Pre-pre-review VR7752: Lu: Targeting histone H3 methylation pathways in CRPC. In appropriate use of t-test for n=3. rec Friday clinic.
  • 7/17: Pre-review round 3: VR6236, passed
  • 7/23: Pre-pre-review VR7659.1: Sosa: Prevention of Lung Adenocarcinoma with Low Dose Aspirin: A Role for Cyclooxygenase in Circulating Tumor Cells and Platelets; used standardized effect sizes
  • 7/23: Pre-review VR7752: Lu : Targeting histone H3 methylation pathways in CRPC (Agboto involved)
  • 7/31: Pre-review VR7659.1
  • 7/31: Pre-review VR7832: Luther: Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism (Chang Yu is statistician at 10%)
  • 8/15: Pre-review round 1: VR8060: S Raj : Modafinil and Cognitive Function in Postural Tachycardia Syndrome: A Pilot Study
  • 9/1: Pre-review round 1: VR8194: M Buchowski: Energy Expenditure and Fatigability in Aging
  • 9/3: Studio: Kecia Carroll (T2)
  • 9/5: Studio: Ken Holroyd (T1)
  • 9/10: Pre-review VR8192: S Bell: Frailty Outcomes in Intensive Care Unit Survivors
  • 9/30: Pre-review round 1: McGregor: VR8212: Parental Perceptions of Pharmacogenetic Testing in Children
  • 10/23: Pre-review round 1: Birdee: VR8432: Focused Breathing Study
  • 11/5: Pre-review round 1: C Wagner: VR8359: Minimally Invasive Mitral Surgery: The Vanderbilt Technique
  • 11/15: Pre-review round 2: Birdee: VR8432: Focused Breathing Study
  • 12/2: Pre-review round 1: E Friedman: VR8036: Biomarkers of cardiac amyloidosis
  • 12/16: Research Design Studio: Bonnie Miller (T2)
  • 12/18: Grant Review Studio: Melissa Wellons: Anti-Mullerian Hormone and Cardiovascular Disease

2014

  • 02-06: Pre-review round 1: VR8994: J Soslow: Evaluating Cardiac Biomarkers in Healthy Children
  • 02-24: Pre-review round 1: VR7436: K Nicholas: CyTOF Characterization of pTFH Cells
  • 02-27: Pre-review round 1: VR9431: W Drake: Genomic Research of AIAT Deficiency and Sarcoidosis (GRADS)
  • 02-27: Pre-review round 1: VR8741: J Herington: Pilot Study to Identify Small-Molecule Modulators (SMMs) that Alter the Regulation of Uterine Contractions (fail; need to include CLs; N as low as 3)
  • 03-05: Pre-review round 1: VR9331: D Moon: Determining the multilocus sequence type (MLST)of samples of non-typhoidal salmonella isolated from bloodstream infections of HIV infected adults in Zambezia Province, Mozambique
  • 03-13: Pre-review round 2: VR9331
  • 03-17: Pre-review round 3: VR9331
  • 03-31: T1 Grant Proposal Studio: Julie Bastarache
  • 04-03: T3 Research Design Studio: Michael Ward
  • 04-09: Pre-review round 1: VR9736: J Nyman: New Tools for Assessing Fracture Risk
  • 04-18: T2 Studio: Tindle and Freiburg: Smoking Cessation
  • 04-21: Pre-review round 2: VR9736: J Nyman: New Tools for Assessing Fracture Risk
  • 04-21: T1 Studio: P Kannannkeril
  • 04-25: T1 Studio: Shanna Arnold
  • 04-29: Pre-review round 1: VR9260: S Minaker: To identify and functionally characterize novel genetic variants in NUP155, hCG1 and GLE1 associated with atrial fibrillation
  • 05-06: Pre-review round 1: VR9936: L Miles Jackson: Epigenetic Modifications in Circadian Clock Candidate Genes of Adolescents at Risk for Major Depressive Disorder
  • 05-08: Pre-review round 2: VR9260: S Minaker: To identify and functionally characterize novel genetic variants in NUP155, hCG1 and GLE1 associated with atrial fibrillation
  • 05-08: Pre-review round 1: VR10013: S Barkin: The Epigenetics of Childhood Obesity
  • 05-10: Pre-review round 1: VR10060: A Seegmiller: Polyunsaturated Fatty Acids and Metabolites as Biomarkers for CFTR Function and Therapeutic Response in Cystic Fibrosis
  • 05-13: Pre-review round 1: VR10152: I Biaggioni: Local heat stress in autonomic failure patients with supine hypertension
  • 05-13: Pre-review round 2: VR10060
  • 06-06: Pre-review round 1: VR10271: D Osborn: Analysis of Simple Cystectomy and Urinary Diversion using the Nationwide Inpatient Sample
  • 06-20: Pre-review round 2: VR10271
  • 06-20: Pre-review rounds 3-4: VR10271
  • 06-23: Pre-review round 1: VR7611.1: E Garland: Autonomic Assessment of a 15 year old Girl with a Congenital Absence of Norepinephrine
  • 06-26: Studio moderator: Landsperger
  • 07-18: Pre-review round 1: VR10411: M Noto: Daily Chlorhexidine Bathing and Infection Rates in Critically-ill Patients
  • 07-30: Pre-review round 1: VR10052: T Mcgregor: K23 MTRNR1 Aminoglycoside induced hearing loss
  • 08-01: Studio: E Brittain: Effect of Chronic PDE5 Inhibition on Energy Expenditure, Cardiopulmonary Performance, and Skeletal Muscle Metabolism
  • 08-16: Pre-review round 1: VR10912: B Oneil: Implications of Increased Reimbursement for Office-Based Management of Bladder Cancer
  • 08-16: Pre-review round 2: VR10912
  • 08-25: Pre-review round 1: VR11052: K Edwards: Phase II Randomized, Partially-Blinded, Controlled Trial in Healthy Adults Aged 65 Years and Older to Assess the Safety, Reactogenicity, and Immunogenicity of an MF59-Adjuvanted, Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered Intramuscularly at Different Intervals and Dosages
  • 08-27: Studio: D Charles: Design of a randomized trial of DBS for early stage Parkinson's disease
  • 09-10: Pre-review round 1: VR11332: A Ikizler: Tissue Sodium in Pre-hypertensive Patients
  • 09-15: Pre-review round 1: VR9911: K Ayres: F18-FES PET/CT Imaging in Desmoid Tumors
  • 09-18: Pre-review round 1: VR11559: B Lehmann: Validation of Novel Gene Fusions In Cutaneous Melanoma
  • 09-30: Pre-review round 2: VR11559
  • 10-01: Pre-review round 2: VR11332
  • 10-11: Pre-review round 1: VR11731: J Phillippi: Patient-Centered, Interprofessional Care in Pregnancy: A Feasibility Study
  • 10-17: Studio: Brummel: Physical activity effects on outcomes of ICU patients
  • 10-28: Pre-review round 1: VR11911: D Cortez: Using iPOND to study the mechanism of action of PARP inhibitors
  • 11-10: Pre-review round 1: VR10613: S Zhao: Use of Antibiotics and Antivirals in Community Dwelling Children with Acute Respiratory Illness
  • 11-17: Pre-review round 1: VR12136: W Heerman: GROW Baby Focus Groups
  • 11-20: Specific Aims Studio: Tim Sterling
  • 11-21: Pre-review round 1: VR11971: M Epplein: Host-Helicobacter pylori co-evolution and protection from atopic disease
  • 12-13: Pre-review round 1: VR12397: J Landsperger: Three Year Outcomes of a Resident Independent Medical ICU Acute Care Nurse Practitioner Service

2015

  • 01-06: Basic science studio: R Gumina
  • 01-10: Pre-review round 2: VR11971: M Epplein: Host-Helicobacter pylori co-evolution and protection from atopic disease
  • 02-10: Pre-review round 1: VR12869: R Tamboli: Role of the Foregut in nutrient metabolism in lean and obese humans
  • 02-20: Analysis Studio: Gordon Bernard: Early, Proactive Prompt for Palliative Care in Outpatient Oncology
  • 02-27: Pre-review round 1: M McClain: VR13212: In vitro model of human CNS myelination
  • 02-27: MSCI Manuscript Studio: Gerald (Jeb) Denny: Nutrition, Inflammation, and Insulin Resistance in End-Stage Renal Disease (moderated)
  • 03-07: Pre-review round 2: VR12869
  • 03-09: Design Studio: Hemnes: PAH
  • 03-13: Pre-review round 1: VR13370: J Luther: Glucose Metabolism in subjects with Aldosterone-producing Adenomas
  • 03-16: Pre-review round 3: VR11731: J Phillippi: Collaboration for Antepartum Risk Evaluation (CARE): A Randomized Controlled Trial of a Patient-Centered Interprofessional Clinic
  • 03-16: Pre-review round 2: VR13212
  • 04-08: Pre-review round 1: VR13594: J Han: Serum Biomarkers of Inflammation, Coagulation, and Neuronal Injury: Their Relationships to Delirium Duration and Functional Decline
  • 04-10: Pre-review round 2: VR13370: J Luther: Glucose Metabolism in subjects with Aldosterone-producing Adenomas
  • 04-17: Pre-review round 2: VR13594: J Han: Serum Biomarkers of Inflammation, Coagulation, and Neuronal Injury: Their Relationships to Delirium Duration and Functional Decline
  • 04-30: Pre-review round 1: VR14394: G Bastas: Objective Assessment Measures for the Clinical Evaluation of Lower Limb Amputee Walking Performance
  • 05-02: Pre-review round 1: VR10713.1: M DeBaun: Inhaled corticosteroid use to prevent acute chest syndrome recurrence in children between 1 and 4 with sickle cell disease: a feasibility trial
  • 05-12: Pre-review round 1: VR13918: T Elasy: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
  • 05-13: Analysis Studio: Leath: Standard gamble utility survey for TBI
  • 05-21: VR14412: G Birdee: Low intensity yoga versus walking for cardiometabolic risk reduction
  • 05-26: Pre-review round 2: VR13918: T Elasy: Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
  • 06-25: T1 Studio: Quinn Wells: Pharmacogenomics of Smoking Cessation
  • 07-13: Pre-review round 1: VR14236: R Reese: Transdermal detection of circulating WBC count in neonates
  • 07-15: Hypothesis generation studio: Yiadom
  • 07-22: T3 Studio: Brett Norman: Palliative Care Unit Pre-Post Study
  • 07-27: Pre-review round 2: VR14236: R Reese: Transdermal detection of circulating WBC count in neonates
  • 08-10: Pre-review round 1: VR14759: C Cascio: Sensory responses in infants at risk for ASD
  • 08-28: Pre-review round 1: VR16159: M Clay: Thermographic Imaging - A Novel Method of Hemodynamic Monitoring
  • 09-08: Pre-review round 2: VR14759
  • 09-25: Pre-review round 1: VR16611: D Khabele: Imaging of COX-1 and angiogenesis in ovarian cancer
  • 10-05: Pre-review round 2: VR16611
  • 10-05: Pre-review round 1: VR16810: A Arnold: Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
  • 10-08: Pre-review round 3: VR15553: Hemnes: A Phase 1b, single center, open-label, dose-escalation, and multiple doese study to evaluate the safety of recombinant human soluble angiotension convering enzyme 2 (rhACE2) in subjects with pulmonary arterial hypertension
  • 10-09: Pre-review round 1: VR10152.1: I Biaggioni: Local Heat Stress in Autonomic Failure Patients with Supine Hypertension
  • 10-15: Pre-review round 4: VR15553
  • 10-20: Pre-review round 1: VR16394: D Zald: Neuromodulation of Decision Making in Young and Middle-Aged Adults: Part 1
  • 10-25: Pre-review round 1: VR16837: L Spalluto: Patient Understanding of Breast Density Reporting
  • 10-26: Pre-review round 2: VR10152
  • 11-07: Pre-review round 1: K Bachmann: VR7408.2: Natriuretic Peptides and Metabolic Risk in Obesity
  • 11-12: Pre-review round 3: VR13355: Kamkwalala: Cholinergic Correlates of Impaired Cognitive Ability in HIV-Associated Neurocognitive Disorders
  • 11-17: Pre-review round 1: VR2122.R1: N Abumrad: RYGB and the Gastric Adipose Axis
  • 11-19: Pre-review round 1: VR17554: J Virostko: Development of 3T MRI/MRS Applications for Diabetes Research
  • 11-20: Pre-review round 4: VR13355
  • 11-20: Pre-review round 1: VR17397: Q Wells: Implementation of Personalized Smoking Cessation Treatment into Clinical Care: Pilot and Feasibility
  • 11-28: Pre-review round 1: VR16441: L Mckernan:The impact of life events and emotional expression on the subjective experience of chronic pain
  • 11-30: Pre-review round 2: VR17554
  • 12-03: Pre-review round 1: VR16931: J O'Neal: Neuroinflammation and postoperative delirium in cardiac surgery
  • 12-06: Pre-review round 3: VR14759
  • 12-07: Pre-review round 2: VR2122.R1
  • 12-11: Pre-review round 1: VR17441: M Burks: Effect of Socioeconomic Status on Care, Treatment, and Outcomes in Women with Gestational Diabetes Mellitus
  • 12-15: T1 Studio: D Aronoff: Repurposing drug for c diff
  • 12-16: Pre-review round 2: VR16931
  • 12-16: Pre-review round 3: VR17554
  • 12-17: Pre-review round 1: VR18011: W Tansey: MYC as a potential driver and anti-cancer target in malignant rhabdoid tumors

2016

  • 01-08: Pre-review round 1: VR14597: C Papantonakis: Pulmonary Complications of Down Syndrome
  • 01-12: Pre-review round 1: VR18012: K Lau: CyTOF single cell study of human colorectal cancers from TCGA
  • 01-12: Pre-review round 2: VR16441
  • 01-14: Pre-review round 1: VR18059: Y Ou: Multimodal Multiplexed Immuno-imaging: Tracking Multiple Immune Markers in Cancer with a Single Nanoagent
  • 01-25: Pre-review round 2: VR18012
  • 02-02: Pre-review round 2: VR18059
  • 02-21: Pre-review round 3: VR18059
  • 02-23: Pre-review round 1: VR18152: I Biaggioni: Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic Failure. Aim 1 of Project 2
  • 03-02: Pre-review round 1: VR18494: D Robertson: Autoimmune Basis for Postural Tachycardia Syndrome
  • 03-03: Pre-review round 1: VR18813: R Cooper: Discrimination, Chronic Stress, and Black MSM HIV Treatment Outcomes
  • 03-05: Pre-review round 1: VR18494: D Robertson: Autoimmune Basis for Postural Tachycardia Syndrome
  • 03-24: Pre-review round 2: VR18813
  • 03-29: Pre-review round 3: VR18813
  • 03-29: T2 Studio: William Heerman: Growth trajectory and future lung function
  • 03-31: Studio: Gordon Bernard: Multi-center RCTs
  • 04-05: T2 Studio: Leena Choi: Population PK/PD Modeling from EHR Data
  • 04-27: Grant proposal Studio: Kathy Hartmann: T32 Clinical/Translational Training Grant
  • 04-28: Pre-review round 1:M Alrifai: VR19697: Randomized controlled trial of a decision support system for protein prescription in premature infants
  • 05-06: Pre-review round 1: C Datye: VR19911: Assessing Barriers to Adherence in Adolescents with Type 1 Diabetes Through Focus Groups
  • 05-14: Pre-review round 2: VR18494
  • 05-16: Pre-review round 1: VR20052: S Peters: Markers of Disease Progression in MECP2 Duplication Syndrome
  • 05-21: Pre-review round 2: VR20052
  • 05-21: Pre-review round 3: VR18494
  • 05-21: Pre-review round 1: VR19536: C Shibao: Title: Phase 2 Norepinephrine Transporter Blockade, Autonomic Failure
  • 05-31: Pre-review round 1: VR19445: J Wang: Trajectories of Physical Frailty in Home Health after Hospital Discharge (TOPFH-HD)
  • 06-02: Pre-review round 1: VR19493: M Hacker: Investigating the Impact of Single Nucleotide Polymorphisms (SNPs) on Outcomes in Parkinsonís Disease Patients Treated with Deep Brain Stimulation versus Medications
  • 06-04: Pre-review round 1: M Neely: VR20245: Metabolomic Phenotype of Parkinsonís Disease Human Neurons Carrying Parkinson's Disease associated PARK-2 mutations
  • 06-08: Pre-review round 2: VR19536
  • 06-15: Pre-review round 3: VR19445
  • 06-29: Pre-review round 1: VR17931: D Moore: Living Kidney Donation: The Impact of Transplant Center Labor and Organization PhD Dissertation
  • 07-28: Pre-review round 1: VR20959: D Markwalter: Family Preparedness for Transitions in Care of Critically Ill Children
  • 07-28: Pre-review round 2: VR19493
  • 07-28: Pre-review round 1: VR21031: M Setliff: Antibody signatures of HIV-infected individuals who develop neutralization breadth
  • 07-29: T1 Studio: Jin Han: Refining Delirium in the ED
  • 08-05: Pre-review round 2: VR21031
  • 08-08: Pre-review round 1: VR11971.2: M Epplein: Host-Helicobacter pylori co-evolution and protection from atopic disease
  • 08-17: Pre-review round 1: VR18731: S Harvey: Guanfacine for PONV and Pain After Sinus Surgery
  • 08-24: Pre-review round 1: VR21410: E Powell: Design and implementation of a curriculum to teach communication skills to pediatric critical care fellows
  • 09-10: Pre-review round 1: VR21011: S Gustafson: Cortical Associates of Speech-in-Noise Perception from Childhood to Adulthood
  • 09-15: T1 Studio: Depak Gupta: Tissue Na+
  • 09-15: Pre-review round 2: VR20245
  • 10-09: Pre-review round 1: VR18760.1: T Iverson: Developing inhibitors of bacterial infective endocarditis
  • 10-10: Pre-review round 1: VR22541: A Kipp: Feasibility of electronic daily diaries for marijuana use motives in people living with HIV
  • 10-13: Pre-review round 1: VR19713.1: T Sethi: A retrospective review of patients diagnosed with Primary Central Nervous System lymphoma (PCNSL) and the impact of treatment modality (chemotherapy +/- radiation therapy) on outcome
  • 10-18: Pre-review round 2: VR18760.1
  • 10-25: T2 Studio: S Gustafson: Cortical Associates of Speech-in-Noise Perception from Childhood to Adulthood
  • 10-27: Pre-review round 2: VR21011
  • 10-27: Pre-review round 1: VR20713: K Cochran: Development and Evaluation of Speculum-Free Diagnostic Cervical Probe
  • 11-17: T2 Studio: David Aronoff: Repurposing drug for CDIF
  • 11-19: Pre-review round 1: VR22411: J Grahl: The Effect of Antibiotic Exposure on the Incidence and Duration of Delirium in Critically Ill Patients
  • 11-29: T1 Studio: Jo Ellen Wilson
  • 12-15: Pre-review round 1: VR21212: R Schulte: Effect of SLCO and other Methotrexate Pathway Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients
  • 12-16: T2 Studio: Sarah Osmundson: Opioid Use Following Cesarean Delivery After Hospital Discharge
  • 12-16: Pre-review round 1: VR23912: A Gamboa: Acute Sympathetic Blockade and Endogenous Glucose Production
  • 12-16: Pre-review round 1: VR23236: K Nicholas: In depth characterization of autoimmune-prone B cells in three patient cohorts
  • 12-29: Pre-review round 1: VR13336.1: S Cortez: Investigating Staff Nurse Experiences with Electronic Documentation
  • 12-29: Pre-review round 2: VR23912: A Gamboa: Acute Sympathetic Blockade and Endogenous Glucose Production

2017

  • 01-10: Pre-review round 1: VR18494.1: D Robertson: Autoimmune Basis for Postural Tachycardia Syndrome
  • 01-13: Pre-review round 2: VR23236
  • 01-13: Pre-review round 1: VR24294: A Link: Functional analysis of candidate human genes regulating the innate immune response
  • 01-18: Pre-review round 1: VR24241: Z Zhao: Development of a Risk Assessment Model for Colorectal Adenoma Recurrence among High-risk Adenoma Patients
  • 01-20: T1 Studio: R Freundlich: Dynamic clinical prediction for acute respiratory decompensation
  • 01-30: Pre-review round 2: VR18494
  • 07-29: Pre-review round 3: VR51356: D Charles
  • 08-17: Pre-review round 3: VR51015: D Gupta: The natriuretic peptide system in African-Americans
  • 08-24: Pre-review round 1: VR51418: S Ejtemaei Mehr: POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME AND GASTROINTESTINAL SYMPTOMS: Contribution of Gastrointestinal Peptides
  • 11-03: Pre-review round 1: VR51834: C Halverson: eMERGE III- Patient Interviews comparator study
  • 12-03: Pre-review round 1:
  • 12-19: T3 Studio: B Damon: Reproducible research and experimental design training grant

2018

  • 01-09: Pre-review round 1: VR51918: K Kuhs: Somatic alterations in human papillomavirus-driven oropharyngeal cancer
  • 01-09: Pre-review round 1: VR52018: D Lee: Clinical Outcomes of the ALPS Proximal Humerus Plating System
  • 01-26: T3 Studio: F Tong: Neursci data science NSF training grant
  • 01-27: Pre-review round 2: VR52018: D Lee: Clinical Outcomes of the ALPS Proximal Humerus Plating System
  • 02-06: Pre-review round 3: VR52018
  • 02-20: Pre-review round 1: VR52166: Back to Bedside: Reducing Resident Administrative Tasks and Increasing Time at Patient's Bedside
  • 04-30: Pre-review round 1: VR51156.R1: A Kamkwalala: Cholinergic Correlates of Impaired Cognitive Ability in HIV-Associated Neurocognitive Disorders
  • 05-11: Pre-review round 2: VR51156.R1
  • 05-11: Pre-review round 1: VR52439: L Crofford: A randomized placebo-controlled, double blind phase 2 clinical trial of memantine for the treatment of cognitive impairment in systemic lupus erythematosus
  • 06-06: Pre-review round 1: VR52556: P Francis: Chemical Genetics to Determine the Antiepileptic Potential of KCC2 Potentiation
  • 07-13: Pre-review round 1: VR51834.R1.1: C Halverson: eMERGE III- Patient Interviews comparator study
  • endfh

Li Wang

2008

  • 01/09/08 - Participated in the Studio for Dr. Ramos.
  • 01/09/08 - Participated in the SRC.
  • 01/15/08 - Ethics meeting.
  • 01/21/08 - Met with Bryan Williams regarding data analysis.K23 MTRNR1 Aminoglycoside induced hearing loss
  • 01/22/08 - Participated in the Studio for Dr. Guzman.
  • 01/23/08 - Participated in the SRC.
  • 01/23/08 - Biweekly biostat CTSA mtg.
  • 01/25/08 - Met with Natasha Halasa and helped on the sample size and statistical analysis plan.
  • 02/06/08 - Met with John Phillips and Revi Mathew on data analysis.
  • 02/14/08 - Met with Bradley Van Sickle regarding analyses for protocol 1794.
  • 02/15/08 - Protocol review.
  • 02/19/08 - Protocol review.
  • 02/21/08 - Participated in cardiovascular clinical trial pre-planning meeting (David Maron, PI)
  • 02/22/08 - Met with Dr.Kelly Birdwell for protocol 1570.
  • 03/04/08 - Participated in the Studio for Dr. Shelagh A.Mulvaney.
  • 03/04/08 - Met with Dr.Kelly Birdwell for protocol 1570.
  • 03/07/08 - 2nd meeting David Maron (with Frank and Dan)K23 MTRNR1 Aminoglycoside induced hearing loss
  • 03/10/08 - Review protocol 1814.
  • 03/11/08 - 3rd meeting David Maron (with Frank and Dan)
  • 03/21/08 - 4th meeting David Maron (with Frank and Dan)
  • 03/24/08 - Met with Dr.Paulette Johnson for protocol 1817 (with Dan Byrne).
  • 03/26/08 - Met with Emily Garland on data analysis plan for CRC protocol 1747 (with Chang Yu)
  • 03/31/08 - Met with Dr.Kelly Birdwell for protocol 1570.
  • 04/02/08 - Met with Dr.Paulette Johnson for protocol 1817.
  • 04/03/08 - Review protocol 1818.
  • 4/04/08 - meet with Reddy for protocol 1821 (with Lei and Dan)
  • 4/08/08 - meet with Hendrik for protocol 1822 (with Lei and Dan)
  • 04/08/08 - Review protocol 1820 and met with Dr.Mary Dietrich.
  • 04/15/08 - Met with Dr.Natasha Halasa on cystic fibrosis project.
  • 04/16/08 - Met with Dr.Muhammad Aslam on weight losing study.
  • 04/17/08 - Review protocol 1827.
  • 04/18/08 - Review protocol 1834.
  • 04/21/08 - Review protocol 1791.
  • 04/23/08 - Participated in analysis studio for Kelly Birdwell.
  • 04/23/08 - Review protocol 1829.
  • 04/29/08 - Met with Dr.Dana Crawford (with Dan Byrne) on genetic lipid study.
  • 04/31/08 - Met with Dr.Natasha Halasa (with Dan Byrne) on CF study.
  • 05/07/08 - Review protocol 1840.
  • 05/09/08 - Review protocol 1843.
  • 05/12/08 - Met with Dr.Wanqing Wen for protocol 1843.
  • 05/16/08 - Met with Dr.Asha Kallianpur for protocol 1843.
  • 05/25/08 - Review protocol 1849, 1864, 1865.
  • 05/27/08 - 05/30/08 Helped with Kelly Birdwell with some graphs for the manuscript.
  • 05/29/08 - Met with Dr Frangoul and Frank to plan analyses for project previously approved for funding in the GCRC model
  • 05/30/08 - Met with Dr Aslam and Dan for protocol 1864
  • 06/10/08 - Participated in Dr Johnson's implementation studio
  • 06/11/08 - Reviewed protocols 1874
  • 06/17/08 - Reviewed protocols 1844
  • 06/19/08 - Met with Dr Frangoul for COBLT study (also on 6/26/08)
  • 07/07/08 - Reviewed protocols 1871, 1880
  • 07/08/08 - Met with Dr Alcendor for protocol 1871; Reviewed revision for protocol 1880
  • 07/08/08 - Met with Dr.Joseph Blake and Chang Yu on the analysis for an abstract submission
  • 07/09/08 - Reviewed protocols 1832, 1889, 1891
  • 07/16/08 - Reviewed revision for protocol 1891
  • 07/17/08 - Reviewed protocols 1893, 1894
  • 07/18/08 - Reviewed protocols 1853
  • 07/21/08 - Reviewed protocol 1897
  • 07/23/08 - Reviewed revision for protocol 1820
  • 07/25/08 - Met with Frank to assist with Franqoul analysis (also 8/18, 8/20)
  • 08/04/08 - Reviewed protocol 1900
  • 08/05/08 - Finished Dr.Joseph Blake's abstract
  • 08/13/08 - Met with Kelly Birdwell on her manuscript revision
  • 08/19/08 - Reviewed protocol 1901
  • 08/20/08 - 09/09/08 Met with Kelly Birdwell and Dan Byrne and worked on her manuscript revision
  • 08/26/08 - Worked on protocol 1878 to make sure it's ready for SRC
  • 08/26/08 - Met with Lisa Wheeler and Chang Yu on her quality of life study design
  • 09/03/08 - Reviewed protocols PF218, PF220, and PF229
  • 09/08/08 - Reviewed revision for protocol PF220
  • 09/12/08 - Reviewed protocol PF234
  • 09/14/08 - Worked on the analysis of Dr.Bryan Williams's Hydroxychloroquine trial for poster presentation
  • 09/23/08 - Reviewed revision for protocol 1807
  • 09/30/08 - Helped Lisa Wheeler on the power and sample size calculation
  • 10/01/08 - 10/23/08 Worked with Dr.Blake on his manuscript
  • 10/22/08 - Reviewed protocol PF264
  • 10/24/08 - Met with Dr.Natalie Curcio and Dan Byrne on USNO project
  • 10/25/08 - Reviewed revision for protocol PF218
  • 10/27/08 - Reviewed protocol PF265
  • 10/31/08 - Met with Kelly King and Dan Byrne on her study design
  • 11/05/08 - Meet with H Frangoul and Frank about analyses for meeting presentation
  • 11/12/08 - Reviewed protocol PF269
  • 11/14/08 - Reviewed protocol PF274
  • 11/17/08 - Reviewed revision for protocol PF265
  • 11/23/08 - Reviewed revision for protocol PF229
  • 11/26/08 - Met with Laurie Lawrence and Dr.Abramo on analysis for an abstract submission (also on 12/2/09)
  • 11/27/08 - Reviewed protocols PF291, PF306, PF307, and PF309
  • 12/09/08 - Reviewed revision for protocol PN_1807
  • 12/12/08 - Met with Dr.Natalie Curcio on USNO database
  • 12/19/08 - Covariate project meeting
  • 12/20/08 - Reviewed protocol PF329

2009

  • 01/02 - Reviewed protocol PF340
  • 01/06 - Reviewed protocol PF349
  • 01/08 - Reviewed protocol PF244
  • 01/09 - Covariate project meeting
  • 01/12 - Met with Dr.Curcio for USNO project
  • 01/13 - Reviewed revision for protocol PF329 and PF340
  • 01/14 - Met with Dr.Frangoul for COBLT study
  • 01/19 - Reviewed protocol PF306
  • 01/21 - Met with Dr.Steve for protocol PF309
  • 01/23 - Minimum dataset project meeting
  • 01/26 - Reviewed revision for protocol PF349
  • 01/29 - Participated in BERD conference call
  • 02/03 - Met with Dr.Scott and Dr.Lily Wang on the study sample size
  • 02/04 - Met with Dr.Curcio on USNO database project
  • 02/05 - Reviewed revision for protocol PF306
  • 02/06 - Reviewed protocol PF364
  • 02/11 - Met with Dr.Sato on the analysis
  • 02/12 - Met with Dr.Frangoul on COBLT study
  • 02/13 - Met with Dr.Curcio on USNO project (also on 02/18/09)
  • 02/20 - Helped Kelly King with her REDCap spread sheet
  • 02/26 - Reviewed revision for protocol PF309
  • 03/03 - Participated Investigator Advocate meeting
  • 03/04 - Reviewed protocols PF334 and PF369, revision of PF364
  • 03/05 - Met with William Jenkins (with Chang Yu) on radiology project
  • 03/09 - 03/12/09 Reviewed protocols PF406, PF407, and PF408
  • 03/10 - Met with Dr.Dineo Khabele for protocol PF364
  • 03/12 - Met with Dr.Curcio for USNO project
  • 03/25 - Reviewed protocol PF420
  • 03/30 - Met with Dr. Frangoul (with Frank) on COBLT paper
  • 03/31 - Reviewed and helped with revision of protocol PF364
  • 04/06 - Reviewed protocols PF429, re-reviewed protocol PF420
  • 04/07 - Meeting with Gordon Bernard and Frank for voucher
  • 04/08 - Met with Natalie Curcio and worked for a conference presentation
  • 04/10 - Covariate project meeting
  • 04/14 - Met with Dr. Jenkins and Worked on the analysis of kidney project (voucher with Chang)
  • 04/27 - Met with Dr. Sato for POTS project
  • 5/12 - Met with Rebekah Brown for CF viral study
  • 6/12 - Met with Pandu Gangula for protocol PF434
  • 6/16 - Met with Dr. Sato for POTS project
  • 6/26 - Met with Raymond Burk, Kristina Hill, and Dan Byrne for selenium project
  • 7/15 - COBLT meeting
  • 7/20 - Met with Marissa Avolio regarding protocol review
  • 7/22 - Reviewed protocol VR214 and VR218
  • 7/22 - Met with William Pao regarding protocol review *7/23 - Reviewed protocol VR204 *7/27 - Met with Maciej Buchowski and Chang YU for chamber project
  • 8/28 - Reviewed protocols VR220, VR75 (2nd round)
  • 8/31 - Reviewed protocol VR318
  • 8/31 - Met with Wonder Drake for protocol sample size issue
  • 9/2 - Reviewed protocol VR329
  • 9/3 - Reviewed protocol VR324
  • 9/11 - Met with Natalie Curcio for skin cancer project
  • 10/14 - Reviewed protocol VR229 and VR96
  • 10/15 - Generated blocked randomization table for Kelly King
  • 10/15 - Met with David Haas for sample size and data analysis
  • 10/16 - Reviewed protocol VR329 (2nd round)
  • 10/26 - Reviewed protocols VR220 (2nd round) and VR470
  • 10/29 - Meeting for voucher VR413
  • 10/30 - Reviewed protocol VR96 (2nd round)
  • 10/30 - Met with Natalie Curcio for skin cancer project
  • 11/2 - COBLT study
  • 11/4 - Met with Rebekah Brown for CF viral study
  • 11/11 - Boot camp meeting
  • 11/16 - COBLT meeting
  • 12/9 - Interim monitoring analysis dataset preparation meeting
  • 12/14 - Met with Maciej Buchowski, Liz Provenzano, and Chang YU for chamber project
  • 12/16 - Met with Raymond Burk, Kristina Hill, and Dan Byrne for selenium project
  • 12/18 - Met with Kelly King for study design and power calculation
  • 12/21 - Pre-reviewed protocols VR443, VR596

2010

  • 1/11 - Pre-reviewed protocol VR555
  • 1/12 - Analysis dataset preparation meeting
  • 1/19 - Met with Haydar Frangoul and Susan Pine for BMI paper
  • 1/19 - Interim monitoring meeting (worked on data management)
  • 1/20 - Met with Dan Byrne for peds tonsil project and worked on the data analysis
  • 1/26 - Worked with Dr.Quasem on protocol VR229
  • 1/28 - Pre-reviewed protocols VR586 and VR291
  • 1/29 - Pre-reviewed protocols VR249.1 and PF404
  • 2/3 - Re-reviewed protocol VR586
  • 2/15 - Pre-reviewed protocol VR349
  • 2/18 - Met with Haydar Frangoul and Frank about BMI paper
  • 2/26 - Pre-reviewed protocol VR424
  • 3/1 - Re-reviewed protocol VR291 and PF404
  • 3/3 - Pre-reviewed protocol VR775
  • 3/11 - Participated studio for Jonathan Moss (peds tonsil project)
  • 3/12 - Reviewed protocol VR291 (3rd round)
  • 3/16 - Pre-reviewed protocol VR714
  • 3/17 - Reviewed protocol VR424 (2nd round)
  • 3/18 - Pre-reviewed protocol VR804
  • 3/19 - Reviewed protocol VR349 (2nd round)
  • 4/2 - Pre-reviewed protocol VR506 and re-reviewed VR443
  • 4/5 - Pre-reviewed protocol VR795
  • 4/8 - Met with Kasasbeh for his vouch with Chang Yu
  • 4/9 - Pre-reviewed protocol VR109
  • 4/14 - Pre-reviewed protocols VR906 and VR604
  • 4/16 - Met with Natalie Curcio for poster presentation
  • 4/19 - Re-reviewed protocol VR795 (2nd round)
  • 4/29 - Met with Kasasbeh for his vouch with Chang Yu
  • 4/30 - Met with Haydar Frangoul, Susan Pine, and Frank Harrell for BMI paper
  • 5/17 - Re-reviewed protocols VR604 (2nd round) and pre-reviewed VR808
  • 5/18 - Pre-reviewed protocols VR943 and VR727

2012

  • 1/11 - discussed VR2255 revision with Chang Yu
  • 1/18 - Met with Paul Newhouse, Kim Albert, and another member of VR2255 team to discuss their application (with Chang Yu).

Lei Xu

  • 3/26/08 - participated CTSA biostat meeting
  • 4/02/08 - participated in SRC
  • 4/03/08 - review protocol 1821
  • 4/04/08 - meet with Reddy for protocol 1821 (with Li and Dan)
  • 4/05/08 - review protocol 1822
  • 4/07/08 - review protocol 1823
  • 4/08/08 - meet with Hendrik for protocol 1822 (with Li and Dan)
  • 4/09/08 - participate CTSA biostat meeting
  • 4/10/08 - review protocol 1824
  • 4/11/08 - review protocol 1830
  • 4/12/08 - review protocol 1833
  • 4/14/08 - met with Erik Boczke for protocol 1824 (with Dan Byrne)
  • 4/16/08 - participated in SRC
  • 4/17/08 - review protocol 1837
  • 4/22/08 - review protocol 1835
  • 4/23/08 - participate CTSA biostat meeting
  • 5/01/08 - met with Yujiang Jia for HIV study
  • 5/07/08 - participated in SRC
  • 5/08/08 - met with PI Jirong Long with Frank for comments of Protocol 1830
  • 5/11/08 - review protocol 1855
  • 5/12/08 - review protocol 1842
  • 5/13/08 - tele conference with Max for protocol 1837 (imaging project)
  • 5/14/08 - participate CTSA biostat meeting
  • 5/14/08 - review protocol 1854
  • 5/16/08 - tele conference with Wes Ely and Max for protocol 1837 (imaging project)
  • 5/20/08 - participate biostat+ethics meeting
  • 5/21/08 - participated in SRC
  • 5/28/08 - participate CTSA biostat meeting
  • 5/29/08 - met with Jonathan Moss for his interim analysis
  • 6/02/08 - review the revision of protocol 1842
  • 6/03/08 - review protocol 1870
  • 6/07/08 - review protocol 1876
  • 6/09/08 - review protocol 1879
  • 6/10/08 - review protocol 1875
  • 6/11/08 - participated in SRC
  • 6/17/08 - met with PI Heidi Silver for protocol 1879 review questions
  • 6/18/08 - participated in SRC
  • 6/25/08 - participate CTSA biostat meeting
  • 6/25/08 - participated in SRC
  • 7/02/08 - participated in SRC
  • 7/03/08 - review revision of protocol 1879
  • 7/16/08 - participated in SRC
  • 7/18/08 - review protocol 1896
  • 7/21/08 - met with Drs. Jonathan Moss, Barr, Deshpand for interim analysis
  • 7/22/08 - met with Wes Ely and Max for their imaging project
  • 7/23/08 - participated in SRC
  • 7/23/08 - participated CTSA biosta meeting
  • 8/4/08 - review 1st revision of protocol 1896
  • 8/5/08 - meet with PI of protocol 1896
  • 8/8/08 - review 2nd revision of protocol 1896
  • 8/11/08 - review protocol 1901
  • 8/21/08 - review protocol 1904, read the draft paper of Yujiang Jia's HIV study
  • 8/26/08 - meet Yujiang Jia at his office
  • 9/2/08 - address questions about protocol 1896
  • 9/3/08 - meet with PI of protocol 1896
  • 9/4/08 - review protocol 230
  • 9/5/08 - review protocol 222
  • 9/9/08 - review protocol 221
  • 9/10/08 - review protocol 224
  • 9/12/08 - review protocol 233
  • 9/17/08 - review revision of protocol 224
  • 9/18/08 - review revision of protocol 230
  • 9/22/08 - review revision of protocol 221
  • 9/23/08 - review protocol 242 and revision of protocol 235
  • 9/24/08 - meet with PI of protocol 224
  • 9/29/08 - review 2nd revision of protocol 224
  • 9/30/08 - review 2nd revision of protocol 221
  • 10/7/08 - review 1st revision of protocol 237
  • 10/8/08 - review 1st revision of protocol 242
  • 10/10/08 - meet with Leena about protocol 242
  • 10/13/08-10/31/08 - perform interim analysis for Dr. Moss
  • 10/28/08 - review protocol 275
  • 11/4/08 - review revision of 1904
  • 11/12/08 - review protocol 257
  • 11/14/08 - review protocol 270 and 279
  • 11/24/08 - review revision of protocol 270
  • 11/27/08 - review protocol 295, 296,and 308
  • 12/15/08 - attend Dr. Hallahan's studio
  • 12/18/08 - review revision of protocol 296
  • 12/21/08 - review protocol 333
  • 1/2/09 - review protocol 342
  • 1/8/09 - meet with Dr. Kantor for PF 270
  • 1/13/09 - review 2nd revision of protocol 270
  • 1/15/09 - meet Nathalie for PF 342
  • 2/20/09 - Participant in Liana Castel's studio
  • 2/21/09 - review RFA 1 application
  • 3/5/09 - review protocol 404
  • 3/12/09 - review protocol 888 (expedited)
  • 3/13/09 - meet with Patrick for revision of protocol 404
  • 3/23/09 - review protocol 421
  • 3/24/09-3/25/09 -revision of protocol 308
  • 3/26/09 - review protocol 422
  • 4/2/09 - participate in Susan Bell's studio
  • 4/6/09 - meet with Otto Sanchez from VUIIS for CTSA voucher
  • 4/8/09- participated in Amanda Wake's studio
  • 4/27/09 - review protocol 437
  • 4/28/09 - review protocol 442
  • 5/7/09 - review revision/response of protocol 422
  • 5/13/09 -participate in Ken Monohan studio
  • 5/15/09 - review protocol 430
  • 5/22/09 - review protocol VR35
  • 5/29/09 -review protocol VR54
  • 6/11/09 - review protocol VR101

Chang Yu

2008

  • 1/04 - Met with Mac Buchowski on his study/data analysis/manuscript
  • 1/2 - 1/3 data analysis and a manuscript for the AASK project, Jay Gainer
  • 1/14 - Helped with Matt Luther's AHA application
  • Reviewed, interacted with the investigators, and wrote report for CRC protocols 1784, 1787,1788, 1790
  • 2/1 Helped with E. Austin's manuscript
  • 2/6 - Met with the investigator regarding analyses for protocol 1541
  • 2/6 - Met with the investigator regarding analyses for protocol 1407
  • 2/6 - Participated the design studio for Don Arnold's funded asthma grant
  • 2/7 - Led the biostatistics clinic
  • 2/11 - drafted the CTSA DBRE brochure and posted it at twiki for team comments
  • Reviewed, interacted with the investigators, and wrote reports for CRC protocols 1798, 1792
  • 2/12 - protocol review
  • 2/18 - data analysis and revision of a manuscript for the AASK project, Jay Gainer
  • 2/17 - 2/18 review and interact with Satish Raj on his CRC protocol 1803
  • 2/20 - generate randomization schedule for Annis Marney, CRC protocol 1744
  • Reviewed, interacted with the investigators, and wrote reports for CRC protocols 1799, 1805, 1803
  • 2/21 - Led the biostatistics clinic
  • 2/27 - Met with Herman Kan on data analyses for his appendix study
  • 2/27 - Met with Todd Tzanetos, Deanna Rae to help her MSCI project
  • 2/28 - Led the biostatistics clinic
  • 2/28 - Met with Gregory Fleming on his milrinone study
  • 3/4 - reviewed protocol 1802.
  • 3/4 - revised VICTR biostatistics brochure.
  • 3/13 - Attended Program of Pulmonary Hypertension group meeting in preparation for the program grant submission
  • 3/14 - protocol review of 1816
  • 3/24 - Partipated in special Biostat/Ethics clinic for assisting with study execution in Sports Medicine
  • 3/24 - Met with Herman Kan on osteomyelitis project analysis
  • 3/26 - Met with Emily Garland on data analysis plan for CRC protocol 1747 (with Li Wang)
  • 3/27 - Attended Program of Pulmonary Hypertension group meeting in preparation for the program grant submission
  • 3/28 - Data analysis for visualized appendix study, Herman Kan
  • 4/4 - reviewed protocol 1826.
  • 4/8 - Data analysis for osteomyelitis project, Herman Kan
  • 4/9 - protocol review of 1825
  • 4/10 - Led the biostatistics clinic
  • 4/10 - Attended Program of Pulmonary Hypertension group meeting in preparation for the program grant submission
  • 4/11 - Met with Gregory Fleming on his milrinone study regarding propensity score analysis
  • 4/13-14 - Propensity score analysis for Gregory Fleming's milrinone study
  • 4/14 - Met with Gregory Fleming, Mias Pretorius, and Nancy Brown to finalize the manuscript for milrinone study
  • 4/17 - protocol review of 1828 and talked to Dr. Ayumi Shintani for the study on 4/21
  • 4/21 - Data and Safety Monitoring Board meeting for the study “The Effect of Nebulized Albuterol on Donor Oxygenation"
  • 4/24 - Led the biostatistics clinic
  • 4/24 - Attended Program of Pulmonary Hypertension group meeting in preparation for the program grant submission
  • 4/24 - met with Eric Austin in preparation for the PAH program grant submission, study design
  • 4/25 - Statistics expert for Dr. Gamboa’s studio
  • 4/25,27,28 - data analyses for the child abuse study by Melissa Hilmes and Herman Kan
  • 5/6 - Discussed with Ayumi Shintani about protocol 1828 (PI Wes Ely)
  • 5/9 - Gave lecture at VICTR CRC workshop, "How to use orthogonal decomposition to d
Topic revision: r486 - 13 Jul 2018, FrankHarrell
 

This site is powered by FoswikiCopyright © 2013-2017 by the contributing authors. All material on this collaboration platform is the property of the contributing authors.
Ideas, requests, problems regarding Vanderbilt Biostatistics Wiki? Send feedback